BioXcel Therapeutics
BTAI
BTAI
86 hedge funds and large institutions have $25.8M invested in BioXcel Therapeutics in 2023 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 34 reducing their positions, and 21 closing their positions.
Holders
86
Holders Change
-2
Holders Change %
-2.27%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
21
Reduced
34
Closed
21
Calls
$1.09M
Puts
$835K
Net Calls
+$255K
Net Calls Change
-$578K
Top Buyers
| 1 |
1
Two Sigma Investments
New York
|
$1.09M |
| 2 |
2
Ameriprise
Minneapolis,
Minnesota
|
$1.69M |
| 3 |
BPA
3
Beacon Pointe Advisors
Newport Beach,
California
|
$763K |
| 4 |
4
Millennium Management
New York
|
$373K |
| 5 |
5
Morgan Stanley
New York
|
$514K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MIM
101
MetLife Investment Management
Whippany,
New Jersey
| – | – | -9,853 | Closed |
|
|
MLICM
102
Metropolitan Life Insurance Company (MetLife)
New York
| – | – | -1,015 | Closed |
|
|
SWM
103
Spire Wealth Management
Mclean,
Virginia
| – | – | -131 | Closed |
|
|
VCM
104
Versant Capital Management
Phoenix,
Arizona
| – | – | -26 | Closed |
|
|
LC
105
Lindbrook Capital
Calabasas,
California
| – | – | -22 | Closed |
|
|
HFS
106
Hantz Financial Services
Southfield,
Michigan
| $0 | 50 | -14 | -22% |
|
|
PA
107
Perceptive Advisors
New York
| – | – | – | – |
|
|
UOC
108
UBS O'Connor
Chicago,
Illinois
| – | – | – | – |
|
|
GTC
109
Ghost Tree Capital
New York
| – | – | – | – |
|
|
ECM
110
Endurant Capital Management
San Mateo,
California
| – | – | – | – |
|
|
CFGS
111
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
HT
112
HAP Trading
New York
| – | – | – | – |
|
113
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $0 | 138 | +58 | +73% |
|